Physician profile
Frederick Yorra
NPI 1770504896
$1,458.95
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,099 · 2020: $335 · 2022: $25.04.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $235.33 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $215.07 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $203.27 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $88.71 | 2019-2020 | |
| Genentech USA, INC. | $86.02 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $83.95 | 2019-2020 | |
| Philips North America LLC | $61.70 | 2019-2020 | |
| Advanced Respiratory, INC | $61.04 | 2019 | |
| Mylan Specialty L.P. | $57.28 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.78 | 2020 | |
| Insmed, INC. | $44.10 | 2019 | |
| Janssen Pharmaceuticals, INC | $40.60 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $38.32 | 2019 | |
| Novartis Pharmaceuticals Corporation | $37.90 | 2019 | |
| Pfizer INC. | $34.99 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $31.71 | 2020 | |
| Circassia INC. | $28.95 | 2019 | |
| Boston Scientific Corporation | $25.04 | 2022 | |
| Paratek Pharmaceuticals, INC. | $19.26 | 2020 | |
| Grifols USA, LLC | $16.93 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Yorra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.